Chronic myeloid leukemia in patient with the klinefelter syndrome

Aim: Genetic inborn along with acquired diseases arise due to the lesions in genome of multipotent hematopoietic stem cells. The aim was to study an influence of constitutional anomaly, Klinefelter syndrome, and additional structural rearrangements on the BCR-ABL tyrosine kinase inhibitor targeted t...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2016
Main Authors: Andreieva, S.V., Korets, K.V., Kyselova, O.A., Ruzhinska, O.E., Serbin, I.M.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/137742
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Chronic myeloid leukemia in patient with the klinefelter syndrome / S.V. Andreieva, K.V. Korets, O.A. Kyselova, O.E. Ruzhinska, I.M. Serbin // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 195–197. — Бібліогр.: 15 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-137742
record_format dspace
spelling Andreieva, S.V.
Korets, K.V.
Kyselova, O.A.
Ruzhinska, O.E.
Serbin, I.M.
2018-06-17T15:47:12Z
2018-06-17T15:47:12Z
2016
Chronic myeloid leukemia in patient with the klinefelter syndrome / S.V. Andreieva, K.V. Korets, O.A. Kyselova, O.E. Ruzhinska, I.M. Serbin // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 195–197. — Бібліогр.: 15 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/137742
Aim: Genetic inborn along with acquired diseases arise due to the lesions in genome of multipotent hematopoietic stem cells. The aim was to study an influence of constitutional anomaly, Klinefelter syndrome, and additional structural rearrangements on the BCR-ABL tyrosine kinase inhibitor targeted therapy efficacy. Material and Methods: We describe a 32-year-old male patient with chronic myeloid leukemia (CML) who was detected to have sex chromosomal abnormality during evaluation for Philadelphia chromosome. Results: At diagnosis of CML, two clones were detected by standard cytogenetic investigation of bone marrow cells: 1) clone with translocation t(9;22)(q34;q11), with two sex X chromosomes and absence sex chromosome Y; 2) clone with t(9;22) and unbalanced t(Y;20)(q11;q13). Analysis of blast transformed lymphocytes from peripheral blood showed karyotype 47,XXY. Monitoring of targeted therapy with second generation inhibitor of BCR-ABL tyrosine kinase indicated a cytogenetic remission and absence of BCR-ABL1 fusion signals after 11 months. Conclusions: Absence of translocation t(9;22)(q34;q11) in blast transformed T-lymphocytes at diagnosis of CML evidences that this translocation may appear not only at the level of multipotent haemopoietic cell progenitors but also may have oligo lineage myeloid origin. Presence of additional structural chromosomal abnormality in the clone with t(9;22)(q34;q11) does not affect the efficacy of therapy with the use of second generation BCR-ABL tyrosine kinase inhibitor.
We thank Prof. Danylo Gluzman, RE Kavetsky IEPOR of the NAS of Ukraine, for the confirmation of the diagnosis and disease stage. We are grateful to Dr. Olena Alkhimova for the valuable advice and assistance.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Short communications
Chronic myeloid leukemia in patient with the klinefelter syndrome
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Chronic myeloid leukemia in patient with the klinefelter syndrome
spellingShingle Chronic myeloid leukemia in patient with the klinefelter syndrome
Andreieva, S.V.
Korets, K.V.
Kyselova, O.A.
Ruzhinska, O.E.
Serbin, I.M.
Short communications
title_short Chronic myeloid leukemia in patient with the klinefelter syndrome
title_full Chronic myeloid leukemia in patient with the klinefelter syndrome
title_fullStr Chronic myeloid leukemia in patient with the klinefelter syndrome
title_full_unstemmed Chronic myeloid leukemia in patient with the klinefelter syndrome
title_sort chronic myeloid leukemia in patient with the klinefelter syndrome
author Andreieva, S.V.
Korets, K.V.
Kyselova, O.A.
Ruzhinska, O.E.
Serbin, I.M.
author_facet Andreieva, S.V.
Korets, K.V.
Kyselova, O.A.
Ruzhinska, O.E.
Serbin, I.M.
topic Short communications
topic_facet Short communications
publishDate 2016
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Aim: Genetic inborn along with acquired diseases arise due to the lesions in genome of multipotent hematopoietic stem cells. The aim was to study an influence of constitutional anomaly, Klinefelter syndrome, and additional structural rearrangements on the BCR-ABL tyrosine kinase inhibitor targeted therapy efficacy. Material and Methods: We describe a 32-year-old male patient with chronic myeloid leukemia (CML) who was detected to have sex chromosomal abnormality during evaluation for Philadelphia chromosome. Results: At diagnosis of CML, two clones were detected by standard cytogenetic investigation of bone marrow cells: 1) clone with translocation t(9;22)(q34;q11), with two sex X chromosomes and absence sex chromosome Y; 2) clone with t(9;22) and unbalanced t(Y;20)(q11;q13). Analysis of blast transformed lymphocytes from peripheral blood showed karyotype 47,XXY. Monitoring of targeted therapy with second generation inhibitor of BCR-ABL tyrosine kinase indicated a cytogenetic remission and absence of BCR-ABL1 fusion signals after 11 months. Conclusions: Absence of translocation t(9;22)(q34;q11) in blast transformed T-lymphocytes at diagnosis of CML evidences that this translocation may appear not only at the level of multipotent haemopoietic cell progenitors but also may have oligo lineage myeloid origin. Presence of additional structural chromosomal abnormality in the clone with t(9;22)(q34;q11) does not affect the efficacy of therapy with the use of second generation BCR-ABL tyrosine kinase inhibitor.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/137742
citation_txt Chronic myeloid leukemia in patient with the klinefelter syndrome / S.V. Andreieva, K.V. Korets, O.A. Kyselova, O.E. Ruzhinska, I.M. Serbin // Experimental Oncology. — 2016 — Т. 38, № 3. — С. 195–197. — Бібліогр.: 15 назв. — англ.
work_keys_str_mv AT andreievasv chronicmyeloidleukemiainpatientwiththeklinefeltersyndrome
AT koretskv chronicmyeloidleukemiainpatientwiththeklinefeltersyndrome
AT kyselovaoa chronicmyeloidleukemiainpatientwiththeklinefeltersyndrome
AT ruzhinskaoe chronicmyeloidleukemiainpatientwiththeklinefeltersyndrome
AT serbinim chronicmyeloidleukemiainpatientwiththeklinefeltersyndrome
first_indexed 2025-12-07T16:18:44Z
last_indexed 2025-12-07T16:18:44Z
_version_ 1850867004099002368